Don't invest unless you're prepared to lose all the money you invest. This is a high risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more
|
|
|
|
|
|
Tharos is an early innovator in the use of malt enzymes for animal gut health. After building a proven, revenue-generating business, they are now ready to replicate that success by launching into the massive canine sector.
Having already raised over £165K from 40+ investors, Tharos is now 100% funded and they are inviting you to join their mission to scale their animal gut health innovations.
Explore this live opportunity below 👇
|
|
🌏 MARKET OPPORTUNITY
Vast Market Potential: The pet and equine supplement market is worth $4+ billion and growing at 7%+ annually, seeing active industry consolidation. Tharos’s 2029 target of £25.6m would represent under 1% of the malt enzymes for animals gut health category.
Sustainability & IP Edge: Tharos is an early innovator protected by four patent families (two granted in the UK + US) delivering a 40-50% lower carbon footprint versus traditional dairy probiotics.
EIS Eligible: This investment offers tax efficiencies for eligible UK taxpayers under the Enterprise Investment Scheme (EIS).
|
|
🚀 TRACTION & KEY ACCOMPLISHMENTS
Proven Traction & Revenue: Tharos delivered £726k revenue in 2025 (based on unaudited management accounts) with 2,500+ active customers, 70%+ repeat purchase rates, and over 19,000 orders fulfilled via a minimal-churn subscription model.
Expert & Elite Validation: Trusted by the Household Cavalry, Met Police, and Blue Cross. Peer-reviewed mechanism paper published in JMAB (Dec 2024). Five
independent study populations — including Blue Cross (80% of dogs reached ideal
stool by week 4), UK Border Force (working dogs pathogen reduction sustained at
2-year follow-up), and a live 81+- dog professional trial (anxiety p < 0.0001).
Multi-Channel & Global Growth: Powered by D2C via veterinary referrals (estimated at 30-40%), social media and animal expert affiliate programs, alongside established B2B partnerships across the UK, EU, USA, and a global corporate white-label customer.
|
|
|
Funds raised in this round will be used to:
Launch Caninectar in the UK D2C: Tharos has recruited over 80 dog professionals, many of whom are signing up for their affiliates program already and micro-influencers to build brand recognition and ensure faster market adoption.
Grow Equinectar-usa.com: Scale up and expand their equine brand presence in the US market utilising the same professional and affiliates strategy.
Grow EU Retail & Vet Channels: Expand European distribution and veterinary channels to replicate the success of zenhorse.fr/en.
|
|
|
|
|
Investing involves risks, including the risk of partial or entire loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Your investment is not covered by a deposit guarantee scheme or by an investor compensation and scheme. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future. Republic Europe does not make investment recommendations to you and any investment decision should be made on the basis of the full campaign. No communications from Republic Europe, through email or any other medium, should be construed as an investment recommendation.
|
|
|
This financial promotion and marketing communication has been approved by Seedrs Limited, authorised and regulated by the Financial Conduct Authority and Seedrs Europe Limited regulated by the Central Bank of Ireland both trading as Republic Europe, on 21 May 2026.
© Seedrs Limited 2026. All rights reserved. Republic Europe is a registered European Community trademark (No. 008771537), registered United Kingdom trademark (No. UK00908771537) and registered United States service mark (No. 85423072). Seedrs Europe Limited is a private company limited by shares registered in Ireland (No. 699574), with registered office at 42, Pearse Street, Dublin 2, D02 YX88, Ireland. Seedrs Limited is a limited company registered in England and Wales (No. 06848016), with registered office at Cubo Soho, Ilona Rose House, Manette Street, London W1D 4AL, United Kingdom, VAT No. GB 208 3065 32.
europe.republic.com is a website owned and operated by Seedrs Europe Limited and/or Seedrs Limited (each trading as Republic Europe).
This message and any attachments are confidential, and may be protected by legal privilege. Nothing in this message shall be considered an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. Republic Europe does not provide legal, financial or tax advice of any kind, and nothing in this email constitutes such advice. If you have any questions with respect to legal, financial or tax matters relevant to your interactions with Republic Europe or its affiliates, you should consult a professional adviser.
Don't want to receive any Featured Campaign Updates? Unsubscribe here. To manage your Republic Europe marketing communications please visit your preferences centre.
|
|
|
|
